BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 27542235)

  • 41. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of apolipoprotein E-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-P.
    Borenstein AR; Mortimer JA; Ding Ding ; Schellenberg GD; DeCarli C; Qianhua Zhao ; Copenhaver C; Qihao Guo ; Shugang Chu ; Galasko D; Salmon DP; Qi Dai ; Yougui Wu ; Petersen R; Zhen Hong
    Am J Alzheimers Dis Other Demen; 2010 May; 25(3):233-8. PubMed ID: 20142627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease.
    Niu X; Wang Y; Zhang X; Wang Y; Shao W; Chen L; Yang Z; Peng D
    Neurol Sci; 2024 Feb; 45(2):547-556. PubMed ID: 37673807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
    Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apolipoprotein E (APOE) ε4 and episodic memory decline in Alzheimer's disease: A review.
    El Haj M; Antoine P; Amouyel P; Lambert JC; Pasquier F; Kapogiannis D
    Ageing Res Rev; 2016 May; 27():15-22. PubMed ID: 26876367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Episodic memory of APOE ε4 carriers is correlated with fractional anisotropy, but not cortical thickness, in the medial temporal lobe.
    Westlye ET; Hodneland E; Haász J; Espeseth T; Lundervold A; Lundervold AJ
    Neuroimage; 2012 Oct; 63(1):507-16. PubMed ID: 22796460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible positive effect of the APOE ε2 allele on cognition in early to mid-adult life.
    Sinclair LI; Pleydell-Pearce CW; Day INM
    Neurobiol Learn Mem; 2017 Dec; 146():37-46. PubMed ID: 29032015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults.
    Hays CC; Zlatar ZZ; Meloy MJ; Bondi MW; Gilbert PE; Liu TT; Helm JL; Wierenga CE
    Neuroimage; 2019 Nov; 202():116162. PubMed ID: 31493534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. APOE genotype and entorhinal cortex volume in non-demented community-dwelling adults in midlife and early old age.
    Bunce D; Anstey KJ; Cherbuin N; Gautam P; Sachdev P; Easteal S
    J Alzheimers Dis; 2012; 30(4):935-42. PubMed ID: 22475794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ApoE ε4 Allele Related Alterations in Hippocampal Connectivity in Early Alzheimer's Disease Support Memory Performance.
    De Marco M; Vallelunga A; Meneghello F; Varma S; Frangi AF; Venneri A
    Curr Alzheimer Res; 2017; 14(7):766-777. PubMed ID: 28176662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential contributions of subregions of medial temporal lobe to memory system in amnestic mild cognitive impairment: insights from fMRI study.
    Chen J; Duan X; Shu H; Wang Z; Long Z; Liu D; Liao W; Shi Y; Chen H; Zhang Z
    Sci Rep; 2016 May; 6():26148. PubMed ID: 27184985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients].
    Zhu XQ; Zhou X; Zhao W; Zhang YM; Liu FJ; Cao J; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1156-1161. PubMed ID: 31006219
    [No Abstract]   [Full Text] [Related]  

  • 53. Opposite Neural Trajectories of Apolipoprotein E ϵ4 and ϵ2 Alleles with Aging Associated with Different Risks of Alzheimer's Disease.
    Shu H; Shi Y; Chen G; Wang Z; Liu D; Yue C; Ward BD; Li W; Xu Z; Chen G; Guo Q; Xu J; Li SJ; Zhang Z
    Cereb Cortex; 2016 Apr; 26(4):1421-1429. PubMed ID: 25336599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The APOE ε4 allele is associated with increased frontally mediated neurobehavioral symptoms in amnestic MCI.
    Mikos AE; Piryatinsky I; Tremont G; Malloy PF
    Alzheimer Dis Assoc Disord; 2013; 27(2):109-15. PubMed ID: 22874659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship of cognitive reserve and APOE status to the emergence of clinical symptoms in preclinical Alzheimer's disease.
    Pettigrew C; Soldan A; Li S; Lu Y; Wang MC; Selnes OA; Moghekar A; O'Brien R; Albert M; The Biocard Research Team
    Cogn Neurosci; 2013; 4(3-4):136-42. PubMed ID: 24168200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
    Batterham PJ; Bunce D; Cherbuin N; Christensen H
    Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Effect of Apolipoprotein E ε4 (APOE ε4) on Visuospatial Working Memory in Healthy Elderly and Amnestic Mild Cognitive Impairment Patients: An Event-Related Potentials Study.
    Gu LH; Chen J; Gao LJ; Shu H; Wang Z; Liu D; Yan YN; Li SJ; Zhang ZJ
    Front Aging Neurosci; 2017; 9():145. PubMed ID: 28567013
    [No Abstract]   [Full Text] [Related]  

  • 60. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
    Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
    BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.